These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15362262)

  • 1. The use of atomoxetine adjunctively in fibromyalgia syndrome.
    Berigan T
    Can J Psychiatry; 2004 Jul; 49(7):499-500. PubMed ID: 15362262
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine.
    Reimherr F; Amsterdam J; Dunner D; Adler L; Zhang S; Williams D; Marchant B; Michelson D; Nierenberg A; Schatzberg A; Feldman P
    Psychiatry Res; 2010 Jan; 175(1-2):67-73. PubMed ID: 19969374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibromyalgia syndrome and depression: common pathways.
    Dunne FJ; Dunne CA
    Br J Hosp Med (Lond); 2012 Apr; 73(4):211-7. PubMed ID: 22585197
    [No Abstract]   [Full Text] [Related]  

  • 4. Are antidepressants effective in fibromyalgia?
    Thomas E; Blotman F
    Joint Bone Spine; 2002 Dec; 69(6):531-3. PubMed ID: 12537258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomoxetine (strattera) for ADHD.
    Med Lett Drugs Ther; 2003 Feb; 45(1149):11-2. PubMed ID: 12571539
    [No Abstract]   [Full Text] [Related]  

  • 6. An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Heiligenstein J; Wilens T; Faries D; Prince J; Faraone SV; Rea J; Witcher J; Zervas S
    J Child Adolesc Psychopharmacol; 2001; 11(3):251-65. PubMed ID: 11642475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder.
    Witcher JW; Long A; Smith B; Sauer JM; Heilgenstein J; Wilens T; Spencer T; Biederman J
    J Child Adolesc Psychopharmacol; 2003; 13(1):53-63. PubMed ID: 12804126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
    Amsterdam JD; Williams D; Michelson D; Adler LA; Dunner DL; Nierenberg AA; Reimherr FW; Schatzberg AF
    Neuropsychobiology; 2009; 59(4):227-33. PubMed ID: 19571597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatments for ADHD and the novel agent atomoxetine.
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2003 Aug; 41(8):12-7. PubMed ID: 13677007
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of dimethacrine].
    Melo I
    Rev Med Suisse Romande; 1971 Mar; 91(3):183-94. PubMed ID: 5092364
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antidepressive medication and cardiovascular disorders: innocuity of clomipramine (Anafranil)].
    Delree G; Korn M; Lepkifker E; Bobon J
    Acta Psychiatr Belg; 1972 Sep; 72(5):602-12. PubMed ID: 4669432
    [No Abstract]   [Full Text] [Related]  

  • 12. [Psychopharmacological study with butryptiline hydrochloride in patients with different depressive disorders].
    Saldaña Hernández OH; Hernández González J
    Prensa Med Mex; 1973; 38(5):215-9. PubMed ID: 4782090
    [No Abstract]   [Full Text] [Related]  

  • 13. An uncontrolled clinical trial with clomipramine in the treatment of depressed patients.
    Campbell P; Gomez L; Ananth JV; Bronheim LA; Klingner A; Ban TA
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):223-31. PubMed ID: 4633284
    [No Abstract]   [Full Text] [Related]  

  • 14. Atomoxetine for attention deficit/hyperactivity disorder.
    Garces K
    Issues Emerg Health Technol; 2003 May; (46):1-4. PubMed ID: 12751480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Doxepin hydrochloride. Clinical value of this new thymoanaleptic agent].
    Richou H; Hug R
    Nouv Presse Med; 1972 Jun; 1(25):1717-8. PubMed ID: 5041723
    [No Abstract]   [Full Text] [Related]  

  • 16. Protriptyline in depression.
    Practitioner; 1968 Sep; 201(203):506-9. PubMed ID: 5683754
    [No Abstract]   [Full Text] [Related]  

  • 17. Suboptimal dosing of Strattera (atomoxetine) for ADHD patients.
    Clemow DB
    Postgrad Med; 2014 Sep; 126(5):196-8. PubMed ID: 25420287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent Raynaud's phenomenon developing from use of atomoxetine in a girl.
    Gökçen C; Kutuk MO; Coşkun Ş
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):428-30. PubMed ID: 23952193
    [No Abstract]   [Full Text] [Related]  

  • 19. An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder.
    Kratochvil CJ; Bohac D; Harrington M; Baker N; May D; Burke WJ
    J Child Adolesc Psychopharmacol; 2001; 11(2):167-70. PubMed ID: 11436956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butriptyline hydrochloride and imipramine hydrochloride in the treatment of non-psychotic depression. A double-blind trial.
    Levinson B
    S Afr Med J; 1974 Apr; 48(20):873-5. PubMed ID: 4597908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.